首页> 外文期刊>Molecular vision >Cell-mediated contraction of vitreous explants from chicken embryo: Possibility of screening for therapeutic agents against proliferative vitreoretinal diseases
【24h】

Cell-mediated contraction of vitreous explants from chicken embryo: Possibility of screening for therapeutic agents against proliferative vitreoretinal diseases

机译:鸡胚玻璃体外植体的细胞介导收缩:筛选针对增殖性玻璃体视网膜疾病的治疗剂的可能性

获取原文

摘要

Purpose: We aimed to establish a novel screening system for identifying potential therapeutic agents for treating proliferative vitreoretinal diseases (PVDs). In this study, we focused on vitreous explants from chicken embryos and evaluated the usefulness of quantitatively analyzing the effects of potential candidates on cell-mediated vitreous contraction, which leads to blindness in PVDs. Methods: Vitreous explants were extracted from 19-day-old embryonic chickens and then incubated with retinal Müller cells or endothelial cells to permit cell adhesion. After cell adhesion occurred, we examined the effect of the attached cells on the wet weight of vitreous explants as an index of vitreous contraction. We also performed hematoxylin and eosin staining to characterize the cell morphology on the vitreous surface. Results: Contraction of the vitreous explants was observed after cell adhesion of not only retinal Müller cells but also endothelial cells. We confirmed the adhesion of these cells on vitreous explants and estimated the number of adherent cells with 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) analysis. The cells on the vitreous surface presented an elongated fibroblast-like phenotype. Integrin was found to be a receptor involved in cell adhesion on the vitreous surface. Discussion: Our results suggest that vitreous explants from chicken embryos may be novel useful tools for screening antiadhesion therapeutic agents in PVDs. This preliminary study must be validated with human vitreous and human retinal pigment epithelial cells.
机译:目的:我们旨在建立一种新型的筛选系统,以鉴定潜在的治疗增生性玻璃体视网膜疾病(PVD)的治疗剂。在这项研究中,我们专注于鸡胚的玻璃化外植体,并评估了定量分析潜在候选物对细胞介导的玻璃体收缩的作用的有用性,玻璃体收缩导致PVD失明。方法:从19日龄的雏鸡中提取玻璃体外植体,然后与视网膜Müller细胞或内皮细胞一起孵育,以使细胞粘附。细胞粘附发生后,我们检查贴壁细胞对玻璃体外植体湿重的影响,作为玻璃体收缩的指标。我们还进行了苏木精和曙红染色,以表征玻璃体表面的细胞形态。结果:不仅视网膜Müller细胞而且内皮细胞都粘附后观察到玻璃化外植体收缩。我们证实了这些细胞在玻璃外植体上的粘附,并通过3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴化物(MTT)分析估计了粘附细胞的数量。玻璃体表面的细胞呈细长的成纤维细胞样表型。发现整联蛋白是参与玻璃体表面细胞粘附的受体。讨论:我们的结果表明,来自鸡胚的玻璃状外植体可能是筛选PVD中抗粘连治疗剂的新型有用工具。此初步研究必须通过人玻璃体和人视网膜色素上皮细胞进行验证。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号